Dr Agarwals Eye Hospital Ltd.

BSE: 526783 SECTOR: Hospital & Healthcare Services  4377   25   0

682.40
+32.45 (4.99%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 682.4

Today's Low

₹ 662.95

52 Week High

₹ 649.95

52 Week Low

₹ 0

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

320.73 Cr.

Enterprise Value

320.16 Cr.

No. of Shares

0.47 Cr.

P/E

21.01

P/B

5.03

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  135.62

CASH

22.2 Cr.

DEBT

21.63 Cr.

Promoter Holding

73.6 %

EPS (TTM)

₹  32.47

Sales Growth

-20.54%

ROE

-2.6 %

ROCE

16.92%

Profit Growth

-110.51 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-20.54%
3 Year-3.03%
5 Year0.47%

Profit Growth

1 Year-110.51%
3 Year-159.66%
5 Year-308.28%

ROE%

1 Year-2.6%
3 Year17.95%
5 Year20.53%

ROCE %

1 Year16.92%
3 Year30.36%
5 Year30.21%

Debt/Equity

0.3957

Price to Cash Flow

9.47

Interest Cover Ratio

1.82367816091954

CFO/PAT (5 Yr. Avg.)

3.5601127661409

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 73.6 99.81
Jun 2021 73.77 99.57
Mar 2021 74.02 99.81
Dec 2020 74.42 99.27
Sep 2020 74.76 98.82
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 30.3646740447754% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of -314.410599676241 days.
  • The company has a good cash flow management; CFO/PAT stands at 3.5601127661409.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.09437201612273.

 Limitations

  • The company has shown a poor profit growth of -159.658543369769% for the Past 3 years.
  • The company has shown a poor revenue growth of -3.02847798086571% for the Past 3 years.
  • Promoter pledging has increased from 73.6% to 99.81% in 1 quarter.
  • Promoter pledging is high as 99.81%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
Net Sales 30.34 42.74 51.71 30.87 58.2
Total Expenditure 24.26 30.06 35.87 25.68 38.89
Operating Profit 6.08 12.67 15.84 5.19 19.31
Other Income 0.07 0.03 0.42 0.32 0.43
Interest 1.66 1.64 1.67 1.44 1.52
Depreciation 4.47 4.92 4.77 5.04 5.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.02 6.14 9.83 -0.97 13.16
Tax 0.03 1.71 8.08 -0.25 3.36
Profit After Tax -0.01 4.43 1.75 -0.73 9.8
Adjusted EPS (Rs) -0.03 9.43 3.73 -1.54 20.86

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 148.54 153.32 170.05 175.95 139.81
Total Expenditure 126.32 129.07 140.07 128.84 109.96
Operating Profit 22.22 24.25 29.97 47.12 29.84
Other Income 1.65 2.3 1.98 2.65 1.95
Interest 4.16 3.41 3.62 8.59 6.96
Depreciation 8.74 9.78 10.91 21.24 19.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 10.97 13.36 17.43 19.94 5.73
Tax 3.64 6.59 5.51 6.26 7.17
Net Profit 7.34 6.78 11.92 13.68 -1.44
Adjusted EPS (Rs.) 15.61 14.42 25.35 29.11 -3.06

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 4.7 4.7 4.7 4.7 4.7
Total Reserves 24.7 30.36 40.89 51.4 49.96
Borrowings 12.91 5.34 13.11 8.49 9.96
Other N/C liabilities 11.2 18.51 26.58 62.18 54.91
Current liabilities 27.45 37.16 35.09 39.36 47.91
Total Liabilities 80.97 96.07 120.37 166.14 167.44
Assets
Net Block 33.21 35.59 54.74 93.58 95.72
Capital WIP 1.22 3.43 0.25 0.02 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 26.59 34.05 35.77 42.87 27.65
Other N/C Assets 0 0 0 0 0
Current Assets 19.95 23 29.61 29.66 44.07
Total Assets 80.97 96.07 120.37 166.14 167.44
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 7.34 13.36 17.43 19.94 5.73
Adjustment 14.93 12.63 13 28.14 27.29
Changes in Assets & Liabilities 1.04 -2.25 2.9 -2.72 4.17
Tax Paid -3.18 -5.17 -8.26 -6.74 -3.33
Operating Cash Flow 20.13 18.57 25.07 38.62 33.87
Investing Cash Flow -7.97 -10.75 -24.8 -16.67 -10.97
Financing Cash Flow -11.74 -8.28 2.12 -19.94 -7.6
Net Cash Flow 0.42 -0.46 2.38 2.01 15.31

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 74.76 74.42 74.02 73.77 73.60
dr sunita agarwal 3.01 2.67 2.27 2.01 1.84
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 25.24 25.58 25.98 26.23 26.40
iepf - 2.48 2.48 - -
investor education... 2.26 - - 2.48 2.48
asha mukul agrawal 1.18 1.18 - - -
rahul jhunjhunwala - - - 1.02 1.02
dipan mahendrabhai... 1.00 - - - -
llp - - - 0.02 -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Dr Agarwals Eye Hsp Stock Price Analysis and Quick Research Report. Is Dr Agarwals Eye Hsp an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dr Agarwals Eye Hsp and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 33.8734 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dr Agarwals Eye Hsp has a Debt to Equity ratio of 0.3957 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dr Agarwals Eye Hsp , the EPS growth was -110.513643108375 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dr Agarwals Eye Hsp has OPM of 21.3464798403536 % which is a good sign for profitability.
     
  • ROE: Dr Agarwals Eye Hsp have a poor ROE of -2.5976019219293 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Dr Agarwals Eye Hsp

X